@shaynahicks1's semaglutide journey, fact-checked

What does this video actually claim?

This TikTok from @shaynahicks1 shares her personal experience with semaglutide, presenting it as part of her New Year's weight loss journey. The video appears to document her ongoing experience with the medication.

While the caption is brief and doesn't make specific medical claims, the framing as a "journey" and connection to 2026 New Year's resolutions suggests she's positioning semaglutide as an effective weight management tool. The video falls into the common pattern of personal testimonials about GLP-1 medications that have flooded social media.

Without seeing specific claims about results or side effects in the actual video content, we can't evaluate detailed medical statements. However, the general framing deserves scrutiny given how often these personal stories oversimplify the reality of semaglutide treatment.

What does the science actually show about semaglutide?

Semaglutide works, but the clinical reality is more complex than most social media posts suggest. The STEP 1 trial (Wilding et al., NEJM, 2021) found that 2.4mg weekly semaglutide led to 14.9% body weight reduction over 68 weeks.

That's impressive, but here's what often gets missed: only 69% of participants completed the full study. The STEP 4 trial (Rubino et al., NEJM, 2021) showed that people regained two-thirds of their lost weight within a year of stopping the medication.

The SUSTAIN 1 trial (Sorli et al., Diabetes Care, 2017) documented side effects in 74% of participants, with nausea affecting 44% of those on the highest dose. These aren't minor details to gloss over in a "journey" narrative.

What's missing from most semaglutide social media posts?

Personal testimonials like this one typically skip the less glamorous parts of semaglutide treatment. The medication requires weekly injections, costs around $1,000-1,500 monthly without insurance, and comes with a lengthy list of potential side effects.

More importantly, these posts rarely mention that semaglutide isn't a temporary fix. The SELECT trial (Lincoff et al., NEJM, 2023) followed participants for over three years, showing that benefits only persist with continued use.

The STEP 5 trial (Garvey et al., Nature Medicine, 2022) demonstrated sustained weight loss over two years, but also confirmed that stopping the medication leads to weight regain. This isn't a diet you complete; it's a long-term medical treatment that requires ongoing medical supervision.

Should you trust TikTok for semaglutide advice?

Absolutely not. While @shaynahicks1 isn't making overtly false medical claims in this particular post, the platform is filled with dangerous misinformation about GLP-1 medications.

A 2023 analysis by the University of Illinois found that 32% of TikTok videos about semaglutide contained medically inaccurate information. Common errors included wrong dosing advice, downplaying serious side effects, and promoting off-label use without medical supervision.

Personal success stories can be misleading because they represent individual experiences, not clinical evidence. The STEP 1 trial showed huge variation in individual responses, with some participants losing less than 5% of body weight while others lost over 20%.

What should you actually know about semaglutide?

Semaglutide is a legitimate, FDA-approved medication that can produce substantial weight loss when used appropriately. However, it's not suitable for everyone and requires careful medical oversight.

The medication is contraindicated for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. The SUSTAIN trials documented serious side effects including pancreatitis, gallbladder disease, and severe gastrointestinal issues.

If you're considering semaglutide, work with a healthcare provider who can evaluate your medical history, monitor for side effects, and develop a comprehensive treatment plan. Social media testimonials shouldn't influence medical decisions about prescription medications.